Insulet
PODD
#1125
Rank
S$21.56 B
Marketcap
$307.54
Share price
0.24%
Change (1 day)
31.81%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.41 B

According to Insulet's latest financial reports the company's current earnings (TTM) are S$0.39 B. In 2023 the company made an earning of S$0.32 B an increase over its 2022 earnings that were of S$56.13 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.41 B25.97%
2023 S$0.32 B481.9%
2022 S$56.13 M-45.24%
2021 S$0.10 B43.35%
2020 S$71.5 M18.51%
2019 S$60.34 M41.16%
2018 S$42.74 M-711.95%
2017 -S$6.99 M-56.85%
2016 -S$16.2 M-79.31%
2015 -S$78.27 M63.85%
2014 -S$47.77 M31.04%
2013 -S$36.46 M-21.96%
2012 -S$46.72 M
2010 -S$44.55 M-42.38%
2009 -S$77.32 M-33.56%
2008 -S$0.12 B65.93%
2007 -S$70.14 M209.75%
2006 -S$22.65 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$9.56 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.18 B-144.47%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.07 B 169.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$26.40 B 6,518.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.47 B 2,025.04%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.35 B 1,742.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$11.70 B 2,834.80%๐Ÿ‡บ๐Ÿ‡ธ USA